Biotechnology Analysis & Statistics in the United States, January 2015

24/7 Customer Support

Talk to Louis

+1 718 618 4302

All regions

1-30 of about 600 reports

Purchase Reports From Reputable Market Research Publishers

U.S. Orthopedic Biomaterials Market

U.S. Orthopedic Biomaterials Market

  • $ 6 995
  • Industry report
  • January 2015
  • by iData Research, Inc.

The fastest growing segments involve stem cells, namely the segments for stem cell bone grafts and concentrated bone marrow. The products within these markets offer the greatest regenerative potential ...

  • Industries : Biomaterial
  • Countries : United States
Global Markets for Implantable Biomaterials

Global Markets for Implantable Biomaterials

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

This BCC Research report examines the global market for medical biomaterials by geographic region and by market segment, and also provides an in-depth discussion and analysis of the application of biomaterials ...

  • Industries : Biomaterial
  • Countries : World, United States
US Biocompatible Materials Market

US Biocompatible Materials Market

  • $ 5 200
  • Industry report
  • December 2014
  • by Freedonia

US demand to grow 5.4% annually through 2018 US demand for biocompatible materials is forecast to grow 5.4 percent annually to $5.5 billion in 2018, representing 2.0 billion pounds. Reflecting quality, ...

  • Industries : Biomaterial
  • Countries : United States
Global Food Safety Testing Market

Global Food Safety Testing Market

  • $ 4 950
  • Industry report
  • November 2014
  • by Global Industry Analysts

This report analyzes the worldwide markets for Food Safety Testing in US$ Million by the following Testing Types: Pathogens Testing, Pesticide Testing, GMO Testing, and Other Testing. The End-Use markets ...

  • Industries : Pesticide, Genomics
  • Countries : World, United States, Japan, Canada, Europe, North America, Germany, France, Asia
Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

  • $ 4 650
  • Industry report
  • November 2014
  • by MarketsandMarkets

The synthetic biology market is rapidly evolving, with various technological advancements that have resulted in a paradigm shift within the market. This has resulted in advanced production of synthetic ...

  • Industries : Genetically Modified Organism, Gmo
  • Countries : World, Europe, North America, Switzerland, France, Germany, United States, Canada, Denmark, Japan, China, Asia
PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy

  • $ 2 995
  • Industry report
  • November 2014
  • by Global Data

PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy Summary GlobalData's report "PharmaSphere: Emerging Biotechnologies - Stem Cell Therapy", provides strategic analysis of the global stem cells ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, Japan, India, China, Asia, World
Articular Cartilage Defect - Pipeline Review, H2 2014

Articular Cartilage Defect - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Articular Cartilage Defect - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Articular Cartilage Defect - Pipeline Review, H2 2014', provides an overview of the Articular Cartilage Defect's ...

  • Industries : Biological Therapy
  • Countries : World, United States
Pharmacogenomics Partnering Terms and Agreements

Pharmacogenomics Partnering Terms and Agreements

  • $ 1 995
  • Industry report
  • November 2014
  • by Currentpartnering

The Pharmacogenomics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomics partnering deals and agreements entered into by the worlds ...

  • Industries : Genomics
  • Countries : United States
Immune Checkpoint Inhibitors Market, 2014-2024

Immune Checkpoint Inhibitors Market, 2014-2024

  • $ 1 899
  • Industry report
  • November 2014
  • by Roots Analysis Private Ltd.

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide. The field of oncology is vast and comprises several indications, including some rare / orphan forms. Although cancer therapeutics ...

  • Industries : Biopharmaceutical
  • Countries : United States
Global Antibody Drug Conjugate Market Outlook 2018

Global Antibody Drug Conjugate Market Outlook 2018

  • $ 1 200
  • Industry report
  • November 2014
  • by RNCOS

For more than a century, the concept of a “magic bullet” to deliver cytotoxic therapy to the site of tumor has been envisioned, but only recently the technological advances enabled antibody-drug conjugates ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Biosimilars Business Review Q4 2014

Biosimilars Business Review Q4 2014

  • $ 1 114
  • Industry report
  • December 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - US Biosimilar Market Edged Closer In 2014, Intensifying Key Debates Industry Brief - Epirus Enters China Collaboration With Livzon Industry Trend Analysis - Amgen's Biosimila ...

  • Industries : Biopharmaceutical
  • Countries : India, China, United States, World
Biotechnology Market in the United States

Biotechnology Market in the United States

  • $ 1 020
  • Industry report
  • November 2014
  • by Ibisworld

IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's May Biotechnology in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis This Industry Risk Ratings report ...

  • Industries : Biopharmaceutical
  • Countries : United States
Seattle Genetics Partnering 2009-2014

Seattle Genetics Partnering 2009-2014

  • $ 995
  • Company report
  • November 2014
  • by Currentpartnering

The Partnering Agreements with Seattle Genetics 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies. This report ...

  • Industries : Genomics
  • Countries : United States
11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

  • $ 895
  • Industry report
  • December 2014
  • by BioPlan Associates, Inc.

The 2014 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current ...

  • Industries : Biopharmaceutical
  • Countries : United States, Europe, World
Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Calypte Biomedical Corporation (Calypte) is a diagnostic service provider. The company carries out development, manufacturing and marketing of in-vitro testing algorithms for improved diagnosis ...

  • Industries : Biopharmaceutical
  • Countries : United States
Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2014 Update

Vermillion, Inc. (VRML) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • November 2014
  • by Global Data

Summary Vermillion, Inc. (Vermillion) is a healthcare service provider. The company develops and commercializes multi-marker, diagnostic tests, which addresses unmet needs in gynecologic oncology and women's ...

  • Industries : Genomics
  • Countries : United States
Brain Resource Limited (BRC) - Product Pipeline Analysis, 2014 Update

Brain Resource Limited (BRC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • October 2014
  • by Global Data

Summary Brain Resource Limited (BRL) is a healthcare service provider. The company carries out research and development of brain products. Its products include MyBrainSolutions, MyCalmBeat, WebNeuro and ...

  • Industries : Genomics
  • Countries : Australia, United States
Physician Views: What opportunity for biosimilar basal insulin?

Physician Views: What opportunity for biosimilar basal insulin?

  • $ 681
  • Industry report
  • November 2014
  • by Firstword Pharma

Two weeks ago, Sanofi significantly downgraded internal revenue projections for Lantus, its long-acting basal insulin treatment, which generated annual sales of $7.6 billion in 2013. The company no longe ...

  • Industries : Biopharmaceutical
  • Countries : United States
Freedonia Focus on Biocompatible Materials: United States

Freedonia Focus on Biocompatible Materials: United States

  • $ 600
  • Industry report
  • December 2014
  • by Freedonia Focus

This report forecasts US biocompatible materials demand in US dollars at the manufacturers' level to 2018. Total demand is segmented by product in terms of synthetic polymers, natural polymers, ceramics, ...

  • Industries : Biomaterial
  • Countries : United States
Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Taiwan, Japan
Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Canada
Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Health Discovery Corporation (Symbol:HDVY) SWOT Analysis, Strategy, Revenues and Profits

Health Discovery Corporation (Symbol:HDVY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Genomics
  • Countries : United States, Georgia
Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
NanoCarrier Co., Ltd. (Symbol:4571) SWOT Analysis, Strategy, Revenues and Profits

NanoCarrier Co., Ltd. (Symbol:4571) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biotechnology, Nanotechnology
  • Countries : Japan, United States
About 1 200 reports

Download Unlimited Documents from Trusted Public Sources

Genomics Industry in the US and the UK

  • January 2015
    10 pages
  • Genomics  

    Genotyping  

  • United States  

    United Kingdom  

View report >

9 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.